Circulating Endocannabinoids Are Reduced Following Bariatric Surgery and Associated with Improved Metabolic Homeostasis in Humans

The therapeutic potential of targeting the peripheral endocannabinoid/CB 1 receptor system

(2018) Joseph Tam et al.   European Journal of Internal Medicine

Probiotics administration following sleeve gastrectomy surgery: a randomized double-blind trial

(2017) S Sherf-Dagan et al.   INTERNATIONAL JOURNAL OF OBESITY

Proximal Tubular Cannabinoid-1 Receptor Regulates Obesity-Induced CKD

(2017) Shiran Udi et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Circulating Endocannabinoids: From Whence Do They Come and Where are They Going?

(2017) Cecilia J Hillard   NEUROPSYCHOPHARMACOLOGY

Global Health Effects of Overweight and Obesity

(2017) Edward W. Gregg et al.   NEW ENGLAND JOURNAL OF MEDICINE

Mechanisms, Pathophysiology, and Management of Obesity

(2017) Steven B. Heymsfield et al.   NEW ENGLAND JOURNAL OF MEDICINE

Bariatric Surgery and Endoluminal Procedures: IFSO Worldwide Survey 2014

(2017) L. Angrisani et al.   OBESITY SURGERY

Serum levels of endocannabinoids are independently associated with nonalcoholic fatty liver disease

(2016) Shira Zelber-Sagi et al.   Obesity

Gastric bypass in morbid obese patients is associated with reduction in adipose tissue inflammation via N-oleoylethanolamide (OEA)-mediated pathways

(2015) Alessandra Quercioli et al.   THROMBOSIS AND HAEMOSTASIS

The Endocannabinoid System: Pivotal Orchestrator of Obesity and Metabolic Disease

(2015) Wilfrid Mazier et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

The Endocannabinoid System in Energy Homeostasis and the Etiopathology of Metabolic Disorders

(2013) Cristoforo Silvestri et al.   Cell Metabolism

Improvement in coronary circulatory function in morbidly obese individuals after gastric bypass-induced weight loss: relation to alterations in endocannabinoids and adipocytokines

(2013) Alessandra Quercioli et al.   EUROPEAN HEART JOURNAL

Circulating endocannabinoids in insulin sensitive vs. Insulin resistant obese postmenopausal women. A MONET group study

(2013) Joseph Abdulnour et al.   Obesity

Nutrition Care for Patients with Weight Regain after Bariatric Surgery

(2013) Carlene Johnson Stoklossa et al.   Gastroenterology Research and Practice

Cut off values for abdominal obesity as a criterion of metabolic syndrome in an ethnic Kyrgyz population (Central Asian region)

(2012) Aibek E Mirrakhimov et al.   Cardiovascular Diabetology

Performance of Biomarkers FibroTest, ActiTest, SteatoTest, and NashTest in Patients with Severe Obesity: Meta Analysis of Individual Patient Data

(2012) Thierry Poynard et al.   PLoS One

Endocannabinoids Measurement in Human Saliva as Potential Biomarker of Obesity

(2012) Isabelle Matias et al.   PLoS One

CB1 Signaling in Forebrain and Sympathetic Neurons Is a Key Determinant of Endocannabinoid Actions on Energy Balance

(2010) Carmelo Quarta et al.   Cell Metabolism

CB1 Antagonism Exerts Specific Molecular Effects on Visceral and Subcutaneous Fat and Reverses Liver Steatosis in Diet-Induced Obese Mice

(2010) T. Jourdan et al.   DIABETES

Splanchnic Balance of Free Fatty Acids, Endocannabinoids, and Lipids in Subjects With Nonalcoholic Fatty Liver Disease

(2010) Jukka Westerbacka et al.   GASTROENTEROLOGY

Biomarkers of Endocannabinoid System Activation in Severe Obesity

(2010) Jack C. Sipe et al.   PLoS One

Sustained Weight Loss After Roux-en-Y Gastric Bypass Is Characterized by Down Regulation of Endocannabinoids and Mitochondrial Function

(2008) Ana Guijarro et al.   ANNALS OF SURGERY

Changes in plasma endocannabinoid levels in viscerally obese men following a 1 year lifestyle modification programme and waist circumference reduction: associations with changes in metabolic risk factors

(2008) V. Di Marzo et al.   DIABETOLOGIA

Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice

(2008) Douglas Osei-Hyiaman et al.   JOURNAL OF CLINICAL INVESTIGATION